|
pravastatin |
|
CHEBI:63618 |
|
A carboxylic ester resulting from the formal condensation of (S)-2-methylbutyric acid with the hydroxy group adjacent to the ring junction of (3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid. Derived from microbial transformation of mevastatin, pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA). The sodium salt is used for lowering cholesterol and preventing cardiovascular disease. It is one of the lower potency statins, but has the advantage of fewer side effects compared with lovastatin and simvastatin. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
Anonymous
|
|
CHEBI:8360
|
|
ChemicalBook:CB6441658, eMolecules:530918 |
|
Molfile
XML
SDF
|
|
|
|
Theophylline, also known as 1,3-dimethylxanthine, is a drug that inhibits phosphodiesterase and blocks adenosine receptors. It is used to treat chronic obstructive pulmonary disease (COPD) and asthma. Its pharmacology is similar to other methylxanthine drugs (e.g., theobromine and caffeine). Trace amounts of theophylline are naturally present in tea, coffee, chocolate, yerba maté, guarana, and kola nut.
The name 'theophylline' derives from "Thea"—the former genus name for tea + Legacy Greek φύλλον (phúllon, "leaf") + -ine. |
Read full article at Wikipedia
|
InChI=1S/C23H36O7/c1- 4- 13(2) 23(29) 30- 20- 11- 17(25) 9- 15- 6- 5- 14(3) 19(22(15) 20) 8- 7- 16(24) 10- 18(26) 12- 21(27) 28/h5- 6,9,13- 14,16- 20,22,24- 26H,4,7- 8,10- 12H2,1- 3H3,(H,27,28) /t13- ,14- ,16+,17+,18+,19- ,20- ,22- /m0/s1 |
TUZYXOIXSAXUGO-PZAWKZKUSA-N |
[H][C@]12[C@H](C[C@H](O)C=C1C=C[C@H](C)[C@@H]2CC[C@@H](O)C[C@@H](O)CC(O)=O)OC(=O)[C@@H](C)CC |
|
environmental contaminant
Any minor or unwanted substance introduced into the environment that can have undesired effects.
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
xenobiotic
A xenobiotic (Greek, xenos "foreign"; bios "life") is a compound that is foreign to a living organism. Principal xenobiotics include: drugs, carcinogens and various compounds that have been introduced into the environment by artificial means.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor
Any EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that inhibits HMG-CoA reductases. Hydroxymethylglutaryl-CoA reductase inhibitors have been shown to lower directly cholesterol synthesis. The Enzyme Commission designation is EC 1.1.1.34 for the NADPH-dependent enzyme and EC 1.1.1.88 for an NADH-dependent enzyme.
(via statin )
|
|
anticholesteremic drug
A substance used to lower plasma cholesterol levels.
(via statin )
|
|
View more via ChEBI Ontology
Outgoing
|
pravastatin
(CHEBI:63618)
has functional parent
(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6,8-dihydroxy-2-methyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid
(CHEBI:63655)
pravastatin
(CHEBI:63618)
has functional parent
(S)-2-methylbutyric acid
(CHEBI:38655)
pravastatin
(CHEBI:63618)
has role
anticholesteremic drug
(CHEBI:35821)
pravastatin
(CHEBI:63618)
has role
environmental contaminant
(CHEBI:78298)
pravastatin
(CHEBI:63618)
has role
metabolite
(CHEBI:25212)
pravastatin
(CHEBI:63618)
has role
xenobiotic
(CHEBI:35703)
pravastatin
(CHEBI:63618)
is a
3-hydroxy carboxylic acid
(CHEBI:61355)
pravastatin
(CHEBI:63618)
is a
carbobicyclic compound
(CHEBI:36785)
pravastatin
(CHEBI:63618)
is a
carboxylic ester
(CHEBI:33308)
pravastatin
(CHEBI:63618)
is a
hydroxy monocarboxylic acid
(CHEBI:35868)
pravastatin
(CHEBI:63618)
is a
secondary alcohol
(CHEBI:35681)
pravastatin
(CHEBI:63618)
is a
statin (semi-synthetic)
(CHEBI:87633)
pravastatin
(CHEBI:63618)
is conjugate acid of
pravastatin(1−)
(CHEBI:63660)
|
|
Incoming
|
pravastatin(1−)
(CHEBI:63660)
is conjugate base of
pravastatin
(CHEBI:63618)
|
(3R,5R)- 3,5- dihydroxy- 7- [(1S,2S,6S,8S,8aR)- 6- hydroxy- 2- methyl- 8- {[(2S)- 2- methylbutanoyl]oxy}- 1,2,6,7,8,8a- hexahydronaphthalen- 1- yl]heptanoic acid
|
pravastatin
|
ChemIDplus
|
pravastatina
|
ChemIDplus
|
pravastatine
|
ChemIDplus
|
pravastatinum
|
ChemIDplus
|
(+)- (3R,5R)- 3,5- dihydroxy- 7- [(1S,2S,6S,8S,8aR)- 6- hydroxy- 2- methyl- 8- {[(S)- 2- methylbutyryl]oxy}- 1,2,6,7,8,8a- hexahydro- 1- naphthyl]heptanoic acid
|
ChEBI
|
pravastatin acid
|
ChEBI
|
4825538
|
Reaxys Registry Number
|
Reaxys
|
81093-37-0
|
CAS Registry Number
|
KEGG COMPOUND
|
81093-37-0
|
CAS Registry Number
|
ChemIDplus
|
|